The gambling industry is facing mounting challenges, from tightening regulations to a surge in identity fraud.

I was soothed only by the feeling of security that came with knowing nobody else could take my 2FA-protected sandwich.

Discover why Novo Nordisk is a top buy with strong GLP-1 drug growth, robust fundamentals, and defensive value.